NovoNordisk gets CDSCO panel okay to study anti-diabetic drug Semaglutide Dr. Divya Colin5 April 2022 5:56 PM ISTNew Delhi: In line with the drug major Novo-Nordisk's justification for anti-diabetic drug Semaglutide the Subject Expert Committee (SEC) of the...
Health Bulletin 19/February/2022 Roshni Dhar19 Feb 2022 5:28 PM ISTHere are Top Health stories for the dayOnline courses to doctors even if mandated by Medical Council should be taxed under GST: AAR Delhi: Medical...
Serdia Pharma gets CDSCO nod for anti-diabetic FDC of extended-release Gliclazide 60mg plus Metformin 1000mg tablet Susmita Roy18 Feb 2022 1:34 PM ISTNew Delhi: In a significant development, Serdia® Pharmaceuticals (India) Pvt. Ltd. has got approval from the Central Drugs Standard Control...
Alkem gets CDSCO panel okay to manufacture, market Metformin, Sitagliptin FDC Medical Dialogues Team12 Nov 2021 6:18 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has granted permission to...
Glenmark gets CDSCO panel nod to study antidiabetic drug Lobeglitazone Sulfate Medical Dialogues Team6 Oct 2021 6:26 PM ISTNew Delhi: In a significant development, drug firm Glenmark has got a green signal from the Subject Expert Committee (SEC) functional under the...
NPPA panel fixes price of Dapagliflozin, Metformin FDC marketed by Lupin Medical Dialogues Team29 July 2021 6:21 PM ISTNew Delhi: With the popular antidiabetic drug, Dapagliflozin, going off-patent, the National Pharmaceutical Pricing Authority (NPPA) panel, giving...
Include more Govt sites in Dapagliflozin, Teneligliptin FDC phase 3 trial: CDSCO panel tells Macleods Pharma Medical Dialogues Team25 July 2021 11:15 AM ISTNew Delhi: Macleods Pharmaceutical has recently received permission from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Glenmark gets CDSCO panel marketing nod to Remogliflozin, Teneligliptin FDC Medical Dialogues Team18 July 2021 11:30 AM ISTNew Delhi: In a major rejoice to Mumbai-based Glenmark Pharmaceuticals Limited, the Subject Expert Committee (SEC) of the Central Drugs Standard...
Include cardiology parameters in clinical trial of anti diabetic drug Lobeglitazone: CDSCO panel tells Glenmark Medical Dialogues Team22 Jun 2021 2:54 PM ISTNew Delhi: In accordance with the proposal presented by pharma major, Glenmark, on the anti-diabetic drug molecule, Lobeglitazone Sulphate Tablets,...
Indian Pharma sees robust growth of 51.5 percent in April sales: AIOCD-AWACS Report Medical Dialogues Team14 May 2021 11:00 AM ISTNew Delhi: The performance of the Indian Pharmaceutical Market (IPM) in April has portrayed a positive outlook for the Indian pharmaceutical industry...
Do sulfonylureas still have a role in blood sugar and diabetes control? Dr. Kamal Kant Kohli11 Jun 2020 12:45 PM ISTAt present, there are a large number of pharmacological agents available for good control of blood sugar and effectively treat type 2 diabetes...
